Genus Oncology, LLC   Report issue

For profit Phase 1
Founded: Vernon Hills IL United States (2007)

Organization Overview

First Clinical Trial
2011
NCT01279603
First Marketed Drug
2007
homatropine
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

GENUS | GENUS LIFESCIENCES